top of page

PATENTS

HEARTXS

HeartXs is a disruptive technique looking at a new access to the left atrium, offering an alternative to cardiac surgery and interventional cardiology.

Surgery
Surgeons

MITRASPEAR

MitraSpear is targeting trans-catheter mitral valve repair (TMVr) and consists of a new truly innovative technique to treat mitral regurgitation.

XCLOSE

XClose is targeting left atrial appendage closure (LAAC) ; simplicity of the mechanism and ease of implantation are key benefits.

Image by Robina Weermeijer
Pipeline: Products
bottom of page